The aim of this study was to retrospectively audit eight years' experience of an IVF surrogate gestational programme and to compare the outcome of surrogacy due lo absence of the ulerus with surrogacy indicated for repeated IVF failure and recurrent abortions. A total of 60 cycles of IVF surrogate pregnancy were initiated in 19 treated couples. Absence of the uterus was the indication for surrogacy in 10 ca.ses: Rokitansky syndrome (eight cases) and post-hysterectomy (two ca.ses) designated as group A. The indications in the remaining nine patients (group B) were: IVF implantation failure (three cases), habitual abortions (four cases) and deteriorating matemal diseases (two cases). IVF performance and subsequent pregnancy outcome of groups A and B were compared. There was no difference in ovarian stimulation parameters and in IVF performance between the groups A and B. The overall pregnancy rate per transfer was 10/60 (17%). The pregnancy rates per patient and per transfer were 7/10 (70%) and 7/35 (20%) in group A compared with 3/9(33%) and 3/25 (12%) in group B, A median number of three treatment cycles were needed to achieve pregnancy. In conclusion. Ihe existence or absence of the uterus in the commissioning mothers is irrelevant for their IVF performance and conception rates. In patients who conceived after more than three IVF cycles, an additional 'oocyte factor" might be present.
Introduction
Traditional or 'natural' surrogacy is defined as where a couple contracts with a woman to be artilicially inseminated with the husband's semen, carry the pregnancy and after delivery give the child and all parents' rights to the commissioning couple. In 'lull' surrogacy, the infertile couple's gametes and the embryos obtained are transferred to the surrogate's uterus to carry such a pregnancy. The surrogate gestation carrier has no genetic link to the fetus. Both types of surrogacy have raised many ethical questions and arc therefore controversial.
Arguments have been raised against commercial surrogacy, claiming exploitation of the surrogates. The gestation carriers have been considered by some as a 'womb to rent '. Comparisons have been made between commercial surrogacy and organ transplant marketing. Gestation surrogacy has even heen described as a form of 'slavery' {Wilkinson. 2003) . Despite all these thoughts, surrogacy has become an established method for producing biologically related children. Surrogacy is a solution for women born without a uterus (Beski et ai. 20()()) and women without a ulerus for various gynaecological and obstetric pathologies (Meniru and Craft, 1997) . Other major indications for surrogacy are repeated reproductive failure after IVF-embryo transfer treatment (both implantation failure and pregnancy loss), for which the exact diagnostic criteria have never been established. Another group of patients are those with a pre-existing disease, which may greatly worsen during pregnancy.
The lirst reported case of a successful IVF surrogate pregnancy was by Utian el ai. in I98.'i. This group further published their extended experience (Goldfarb ei ai. 2000) . Other groups in Britain (Brindsen et ai. 2000) . Australia (Stafford-Bell andCopeland. 2001) and Finland (SoderstroniAnttila ei ai. 2002) . published their local experience in IVF surrctgacy. Woodward et ai (2004) recently described the hirih of healthy twins, following surrogacy involving a female patient's biological mother as surrogate, using anonymous donated embryos. The legal side of adoption took over 3 years to complete, emphasizing the ever-widening gap between artilicial reproductive technology and laws governing Ihe technology.
The aim of this study was to evaluate retrospeciively cighl years' experience of an IVF surrogate gestational programme in one tertiary care and academic centre.
Experience with 60 I VFcycles of IVF surrogacy was reviewed. Further, the variables of surrogate mothers withuul a uterus were compared with those of mothers with a functional uterus (suffering from recurrent abortions and implantation failure).
Guidelines for surrogacy in Israel
Stale-controlled surrogacy has been legislated in a very few countries around the world. In Israel, it represents a compromise between orthodox and liberal approaches (Benshushan and Schenker, 1997) . The new surrogacy law in Israel has been valid since March 1996 (Frenkel, 2001) . A multidisciplinary commiltee must approve every case of surrogacy. The commiltce includes: a gynaecologist, an internal medicine physician, a clinical psychologisl. a social worker. a clergyman and a lawyer as public representatives. Only full surrogacy is permitted. Both partners of the commissioning couple should provide ihe gametes. Sperm donation is not allowed. Ovum donation is allowed as an exception, with the approval ofthe committee. The parlies should be adult Israeli citizens to prevent abuse of foreign women without legal residency siatus. The surrogate mother should be unmarried, single or divorced, with at least one child oi her own. She should be anonymous to the commissioning couple to avoid any potential pressure on relatives of the family to become surrogate. The surrogate and the commissioning couple should be of the same religion. The surrogate mother receives a fixed payment for her service. The payments are approved by the committee. An additional sum of money is kept for further expenses such as psychological aid. Surrogacy is restricted to only two deliveries by the same surrogate mother. The child is under the responsibility ofa social worker from birth until Ihe momeni of completion of an adoption procedure wilhin 7 days from delivery (Honig et ai. 2000) .
Materials and methods
The medical records of 19 patients participating in surrogacy gestation that occurred during the years 1997 to 2004. at Assaf Harofeh Medical Centre. Zerilin. Israel, were reviewed (Table 1) , Absence of the uterus was the indication for surrogacy in 10 of 19 cases: Rokitansky syndrome (eighi cases) and post-hysterectomy (two cases) -group A, Hysterectomy was performed because of bleeding cervical pregnancy in one case and an extremely large fibroid uterus causing menometrorrbagia. in the second patient. The indiealions for surrogacy in the remaining nine group B patients were: IVF implantation failure (three cases), habitual abortions (four cases) seriously impaired renal function post-renal iransplantalion in one patient, and an endangering oestrogendependent congenital haemangioma around the area of the neck in one patient. Of these nine patients, three had never conceived. One of the remaining six patients had suffered from 24 consecutive abortions (Raziel et ai. 2000) . one had suffered from six conseculive abortions, and one had conceived and delivered after 12 IVF trials. On her repeated attempts for a second child she underwent another 12 trials that failed to achieve pregnancy and she was therefore referred to surrogacy. The 'original' female and male gametes were transferred in all cases to the surrogate mother.
The age of the patients, day 3 basal serum FSH and LH values were as.sessed. Regarding ovarian slimulation: duration of treatment and number of gonadolrophin ampoules needed for stimulation, hormonal prohle (ocstradiul. progesterone), number of follicles, aspirated ooeytes. and total number of developing and transferred embryos were compared and evaluated. Article -IVF surrogiUc i^e.statJonal pregnancy programme -A Raziel el ai Ovarian stimulation was carried out by the intramuscular administration of 3.75 mg triptorelin (Decapeptyl: Ferring. Malmo. Sweden) or 600 |.ig intranasal nafarelin (Synarel: Delpharm. France) two weeks prior to individualized administration of human menopausal goiiadotrophins (Menogon: Ferring. Manheim. Germany) or recombinant preparations (Gonal F -Serono. Aubans. Switzerland: Puregon -Organon. Lausanne. Switzerland). For the treatment of patients with Rokitansky syndrome, weekly determination of serum progesterone to identify accurately ihe luteal phase and thus administer gonadotrophin-releasing hormone (GnRH) analogue preparation was done as suggesled by Ben-Rafael ('/ ai. 1998. Oocyte retrieval was performed by vaginal route guided by ultrasound under general anaesthesia. The morphology of each of the aspirated oocytes. after denudation with hyaluronidase. was described. Intracytoplasmic sperm injection (ICSI) was carried out in all palients according to the methodology described by Van Stcirteghem et aL. 1993 , II is our rule to perform IVF when possible. As in other IVF units. ICSI is performed when the semen quality ofthe patient is low on previous failed IVF cycles and in low responders. Since our fertilization rate and emhryo quality are often better in ICSI than in IVF (as we see in mixed IVF/ICSI cycles), we prefer to perform ICSI ralher than IVF in these unique cases of surrogacy.
Fertilization was confirmed after 16 to 18 hby visualization of two distinct pronuclei. Cleavage was assessed 24 h laler. Grade I embryos were defined as embryos in which all blastomeres were of equal size, grade II embryos had blastomeres with unequal or equal size with a maximum of 20'/f fragments ofthe embryo volume. In grade 111. 20-50'7c ofthe volume contained fragmentation and if >509'f fragmentation was present. Ihe morphology of the embryo was classed as grade IV, Embryos were considered for transfer and introduced into the uterine cavity 48-72 h after the iCSI procedure, hmbryo transfer was performed wiih a Wallace catheter (Simcare. Lancing. UK).
In order lo synchronize the commissioning mother and the surrogaie. the latter used oral contraceptives during the pituitary desensitization of the commissioning mother. The surrogate mother was instructed to stop the ingestion of oral contraceptives so she had withdrawal bleeding in parallel with the start of individualized gonadotrophin injection in the commissioning mother.
Pituitary desensitization was not used in the gestational carrier for synchronization. The surrogate mother started daily oral oestradiol valerate in escalating doses, starting at 2 mg/day up to a maximum o\' 6 mg/day in an individualized fashion, A minimal endometrial thickness of at least 6 mm triphasic endometrium was attained before transfer was attempted. Intramuscular progesterone in oil (Gestonc: Paines and Byrne. Surrey. UK) 50 mg perday. or vaginal micronized progeslerone (Utrogestan: Besins Inieniationai Laboratories. Paris. France) 200 mg every 8 h. were added to the surrogate, starling on the human chorionic gonadotrophin (HCG) day of Ihe biological mother. If pregnancy was diagnosed, this combined regimen was continued until 8 weeks of gestation.
Pregnancy rate was calculated considering only clinical pregnancies, determined by the visualization of a gestational sac by transvaginal ultrasound 3 to 4 weeks after embryo transfer. Early abortion was defined as pregnancy loss that took place before 12 weeks of gestation, and a late abortion after 12 and before 20 weeks of gestation.
Statistical analysis
Results were expressed as means ± SD, Statistical analysis was performed with the JMP statistical package (version 3.2.2.; SAS Institute Inc. Cary. NC, USA) using Student's rtesi as appropriate. Statistical significance vvas defined as a value of/>< 0,05,
Results
Pertinent clinical data on ovarian slimulalion and IVF performance are depicted in Table 2 .
A mean number of 10 ± 5,2 oocytes were aspirated from the commissioning mothers. Of 494 oocytes, 430 (87%) were mature. 30 (6%) were metaphase I oocytes and those remaining were at the germinal vesicle (1 %) and degenerated (6%) stages, A mean number of 5,3 ± 3.2 embryos were observed, of which a mean number of 2.6 ± 0,9 embryos were transferred. Of 143 embryos, 61 (43'7f) were "good" quality (grades I, I-ll). 76 (537f) were 'intermediate" quality, and the remaining 4V( were bad-quality embryos (grade HI or above).
Patients with congenital or acquired absence of Ihe uterus were signiticantly younger than patienis with repealed abortions or repeated IVF trials {P < 0,001), Ovarian stimulali{>n and IVF outcomes of those patients are shown in Table 3 . There was no difference in any of the parameters between the Iwo groups except for a significantly higher mean serum oestradiol concentration on HCG day in group A, Four palients underwent only one surrogaie IVF trial and all of them conceived. Five patients underwent two surrogate IVF cycles. Pregnancy was achieved in one of these palients. Pregnancy was reported in two of another four patients who performed three surrogate IVF cycles. Two patients underwent four surrogate IVF trials without any pregnancy. One pregnancy was achieved in iwo patients who underwent five surrogate IVF trials. Conception was achieved in another two patients after seven and after nine IVF trials respectively. One surrogate was pregnant twice: the first pregnancy, on the first IVF trial, ended in a missed abortion. The second surrogate IVF pregnancy was after another ihree successive cycles. It ended in a normal delivery.
The overall pregnancy rate pertransfer was I77r ( UV60), and a live birth rate of I59( (9/60) per cycle was found. The pregnant patients underwent a median of three treatment cycles. Six of 10 pregnancies were achieved in patients with absence ofthe uterus. 31,2 ±3.K 6.0 ± 2,5 4.8 ±2,1 35,0 ± 11,9 12,0 ± 1.3 3131 ± 17 11 1,4 ±0,7 12 ±4.8 10.6 ± 4,3 8,8 ± 3.2 6,5 ± 2.7 5,4 ± 2.7 2,7 ±0.9
(iroiip H in -251
35.4 ±3.9 5,9 ± 2.2 5,3 ± 1.9 35 ± 15.8 11 ± 2,5 2.'^42± 1628 1,5 ± 0,4 10,0 ±6.3 8.9 ±6,2 6.8.0 ± 4,2 5.0 ± 3,7 5.2 ± 3,8 2.5 ±0,7 
Discussion
Despite the fact that surrogacy has become an integral part of infertility management, only tew studies have been published concerning IVF surrogacy, ihe perinatal outcome and followup of the children born. Most publications on surrogacy discuss mainly the ethical tlilemma and legislalion, rhe largest recent study published today on gestational surrogacy, among others (Marrs et aL. 1993; Serafini et aL. 1994; Brinsden et aL. 2000) is the one by Goldfarb et al.. 2000 . This study covered a t5-year period during [1984] [1985] [1986] [1987] [1988] [1989] [1990] [1991] [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] . and 180 cycles in 112 couples. Although the number of cycles is impressive. IVF procedures changed through these years: the administered drugs, surgical approach, kind of anaesthesia, the skill and media in the IVF laboratory. According to tbeir experience, a mean of I I.I ooeyles were retrieved. 7.1 fertilized. 5.8 cleaved and 3,2 were transferred. These parameters were similar to those in the current series. However, they found a better surrogate IVF performance in patients with congenital absence o\' the uterus, as compared with patients post-hysterectomy. This was attributed to the possibility of compromised ovarian vascularity caused by previous surgery. Corson ct al. in I99H, in another analysis between the years WSX and 1997 of 77 couples, citutd not find a difference in the above paramelcrs between congenital absence of ihe uterus and post-hysterectomy. The mean age of the patients with Rokltansky syndrome was significantly lower among ihe patients compared wiih post-hystcrcctomy, as in the current study. According to the above, ihe concept thai patients with congenital absent uterus respond to ovujation induction better than patients who have undergone hysterectomy remains open tor discussion.
The number of patients without a ulerus in the present series was relatively low; therefore a comparison between IVF performance in patients with congenital and acquired absence (tf the uterus was not done. Results in paticnis without a ulerus (mostly congenital and also acquired) were compared with those from WF surrogacy due to repeated abortions or IVF failures in the commissioning mother. It should be noted that group B included different aetiopathologies. and it would have been more appropriate lo compare patients with absent uterus with patients in each of the distinct pathologies. Sueh a comparison was not possible due to the small number of patients. No diflerenee was found in IVF performance between groups A and B so it can be assumed that the existence or the absence of the uterus is irrelevant lo the IVF perlormanee in IVFsunogaey.
The pregnancy rate per transfer was 17'^ (10/601. and the live birth rate 15'/; (9/60). These numbers arc somewhat low compared wiih the 'regular IVF programme'; pregnancy and live birth rates of 30% and 25.5%, respectively. Similar results were reported by Goldfarb et oi (2000) : a clinical pregnancy rate of 3O/15S (19%) and a live birth rate of 2.'i/l58 (16*%^). However. Corson ei al. . in 199X reported a pregnancy rate of 30.8'7( per cyele. in palients under the age of 40 years, in 117 fresh and eryopreservation cycles. No pregnancy was achieved in patients aged over 40 years, in 27 cycles. Reasons for the low pregnancy rates arc unknown. They may be related to dilTerent characteristics of the patients such as older age and/or the presence of prominent "oocyte factor". In summary. IVF surrogacy is a well-established treatment in cases of congenital absent uterus, posi-hysterectomy and in patients with recurrent abortions or IVF failures. The existence or absence of the uterus was irrelevant to the performance in IVF. The overall pregnancy rate per transfer was I7'7f (10/60) and a live birth rate of LS' /r (9/60) per cycle was found. A median of three surrogate IVF cycles is needed to achieve a pregnancy.
